Edition:
United States

Nestle SA (NESN.F)

NESN.F on Frankfurt Stock Exchange

75.26EUR
12:40pm EDT
Change (% chg)

€-0.66 (-0.87%)
Prev Close
€75.92
Open
€76.19
Day's High
€76.39
Day's Low
€75.00
Volume
6,378
Avg. Vol
40,430
52-wk High
€79.13
52-wk Low
€62.20

NESN.F

Chart for NESN.F

About

Nestle S.A. is a nutrition, health and wellness company. The Company's segments are Zone Europe, Middle East and North Africa (EMENA); Zone Americas (AMS); Zone Asia, Oceania and sub-Saharan Africa (AOA); Nestle Waters; Nestle Nutrition, and Other Businesses. The Company operates in the United States, Greater China Region,... (more)
No analyst recommendations are available for NESN.F.

Overall

No Ratios Available.

Financials

  NESN.F Industry Sector
P/E (TTM): -- 22.32 40.74
EPS (TTM): -- -- --
ROI: -- 12.54 52.38
ROE: -- 15.74 59.98

Nestle CEO plays down chances of deal rush: Manager Magazin

ZURICH Nestle Chief Executive Mark Schneider played down the chances of a rush of deals involving the Swiss food group after the company said last month it may sell its roughly $900 million-a-year U.S. confectionery business.

8:04am EDT

Nestle CEO doesn't rule out larger buys in health ops: Manager Magazin

BERLIN Nestle Chief Executive Mark Schneider does not rule out larger acquisitions in health-science operations to prop up sales, according to Germany's Manager Magazin.

8:04am EDT

Nestle CEO doesn't rule out larger buys in health ops -Manager Magazin

BERLIN, July 20 Nestle Chief Executive Mark Schneider does not rule out larger acquisitions in health-science operations to prop up sales, according to Germany's Manager Magazin.

7:59am EDT

Nestle CEO plays down chances of deal rush - Manager Magazin

ZURICH, July 20 Nestle Chief Executive Mark Schneider played down the chances of a rush of deals involving the Swiss food group after the company said last month it may sell its roughly $900 million-a-year U.S. confectionery business.

6:23am EDT

BRIEF-EnWave ‍signs new technology evaluation and license option agreement with Nestlé​

* Enwave corp- ‍signed a new technology evaluation and license option agreement with nestec ltd., a subsidiary of nestlé s.a.​

Jul 12 2017

Nestle invests in microbiome-based diagnostics venture

ZURICH Food group Nestle's health science business is investing 20 million euros ($22.8 million) in a joint venture with pharma and diagnostics company Enterome SA to develop microbiome-based diagnostics for inflammatory bowel and liver diseases, Enterome said on Tuesday.

Jul 11 2017

Nestle invests in microbiome-based diagnostics venture

ZURICH, July 11 Food group Nestle's health science business is investing 20 million euros ($22.8 million) in a joint venture with pharma and diagnostics company Enterome SA to develop microbiome-based diagnostics for inflammatory bowel and liver diseases, Enterome said on Tuesday.

Jul 11 2017

Activist Loeb keeps up performance pressure on Nestle: source

LONDON Activist investor Daniel Loeb is keeping up pressure on Nestle by sharing views with the company as part of a regular dialogue, a source familiar with the matter told Reuters.

Jul 11 2017

UPDATE 2-Activist Loeb keeps up performance pressure on Nestle -source

LONDON, July 10 Activist investor Daniel Loeb is keeping up pressure on Nestle by sharing views with the company as part of a regular dialogue, a source familiar with the matter told Reuters.

Jul 10 2017

UPDATE 1-Activist Loeb keeps up pressure on Nestle - source

* Nestle shares pare gains made in wake of Loeb letter (Updates with details of Nestle campaign)

Jul 10 2017

Earnings vs. Estimates